Tapping into the precision molecule-editing potential of halogenases
What if we could precisely edit molecules in one step? What if we could add a ‘Lego handle’ to a molecule at an exact position – in a ‘best-to-reach’ chemical space – and then build onto the molecule from there? These are the questions that spurred Rebecca Goss (left) – Professor in biomolecular/organic chemistry at the University of St Andrews (UK) and CEO of spinout precision molecular editing company X-Genix – to develop a new technology. We spoke with Rebecca at ELRIG’s Drug Discovery 2025 (21–22 October; Liverpool, UK) to find out more about this precision editing platform and what...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!